Full-Time

Director – Cell and Molecular Biology

Posted on 9/24/2024

Verve Therapeutics

Verve Therapeutics

201-500 employees

Develops gene editing therapies for cardiovascular disease

Biotechnology
Healthcare

Senior

Boston, MA, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • Advanced degree (MS or PhD) in Molecular/Cell Biology, Genetics, Virology, Bioengineering, or related life sciences field with strong scientific background and 10+ years’ relevant experience.
  • Proven experience in oligonucleotide analytical qPCR, RT-qPCR, cell-based assays and/or NGS method development, quality control processes and hand-on experience with state-of-the-art analytical instruments.
  • Prior laboratory operations and management experience leading a team of scientists and associates for analytical development in a clinical stage biotech environment.
  • Prior experience performing analytical assays to support the development of lead molecules, troubleshooting and optimizing analytical assays for GMP use per ICH guidelines.
  • Experience with planning and executing product and process development studies such as forced degradation, comparability assessments, stability, etc.
Responsibilities
  • Oversee a vibrant team working on mRNA and guide RNA cell-based potency assays using varied delivery methods (e.g., Lipid nanoparticles).
  • Extensive experience in molecular biology, mammalian cell biology techniques and assays.
  • Manage the development, qualification and transfer methods to the quality control group or external testing labs.
  • Serve as analytical lead for CMC project teams.
  • Oversee troubleshooting, tech transfer, and phase-appropriate GMP validation of analytical methods at the Verve internal Quality Control lab and at contract testing labs in collaboration with Verve Quality Control.
  • Author and review technical reports and regulatory submissions.
  • Provide guidance and support to team members, promoting their professional growth and development.
  • Effectively manage multiple projects to ensure timely delivery.
  • Foster a culture of lab safety, data integrity, collaboration, innovation, continuous improvement and accountability within the team.
  • Other duties as assigned.

Verve Therapeutics focuses on developing gene editing therapies to treat cardiovascular disease. Their approach involves creating single-course treatments that aim to provide lasting solutions rather than ongoing management. The company specifically targets the PCSK9 and ANGPTL3 genes, which are known to help lower blood lipid levels. This focus on gene editing sets Verve apart from traditional therapies that require continuous treatment. Their goal is to offer potentially curative options for patients with cardiovascular conditions, generating revenue through the commercialization of their therapies and partnerships with other healthcare entities.

Company Stage

IPO

Total Funding

$353.6M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eli Lilly's $60M investment shows confidence in Verve's cardiovascular gene editing approach.
  • CRISPR therapy approvals like Casgevy suggest a regulatory path for Verve's treatments.
  • CRISPR's success in genetic blindness supports Verve's innovative gene editing potential.

What critics are saying

  • CRISPR therapy competition is intense, with companies like Vertex achieving landmark approvals.
  • Most CRISPR therapies are in early stages, delaying Verve's market entry and revenue.
  • Verve's stock drop post-offering may reflect investor concerns about financial stability.

What makes Verve Therapeutics unique

  • Verve focuses on cardiovascular diseases, unlike many CRISPR companies targeting oncology.
  • Their single-course gene editing offers a potential cure, not just chronic management.
  • Verve targets well-validated genes PCSK9 and ANGPTL3 for lipid level reduction.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE